Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MB05032 targeted the AMP binding site of fructose 1,6-bisphosphatase (FBPase), which is a special and efficacious inhibitor of GNG.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 112.00 | |
25 mg | 6-8 weeks | $ 613.00 | |
50 mg | 6-8 weeks | $ 797.00 | |
100 mg | 6-8 weeks | $ 1,390.00 | |
1 mL * 10 mM (in DMSO) | 5 days | $ 217.00 |
Description | MB05032 targeted the AMP binding site of fructose 1,6-bisphosphatase (FBPase), which is a special and efficacious inhibitor of GNG. |
Targets&IC50 | FBPase (human Liver):16 nM |
In vivo | In young ZDF rats with mild diabetes and aged ZDF rats, MB06322 (3/6-300 mg/kg (young/aged Zucker diabetic fatty (ZDF) rats); p.o.; once) causes dose-dependent glucose lowering with overt diabetes [1]. |
Molecular Weight | 302.29 |
Formula | C11H15N2O4PS |
CAS No. | 261365-11-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (165.40 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MB05032 261365-11-1 Others MB-05032 MB 05032 inhibitor inhibit